PVI
PFE icon

Partners Value Investments’s Pfizer PFE Stock Holding History

Partners Value Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,097
Closed -$1.63M – 25
2017
Q1 		$1.63M Buy
+50,097
New +$1.58M 0.27% 22

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Partners Value Investments's PFE Position: Q2 2017 in Review

Partners Value Investments sold out of Pfizer (PFE) in Q2 2017, closing a stake of 50,097 shares — an estimated $1.63M sold.

Partners Value Investments first reported a position in PFE in Q1 2017 and held it in 1 quarter. The position peaked at $1.63M in Q1 2017. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Partners Value Investments reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • Partners Value Investments sold 50,097 Pfizer shares in Q2 2017, an estimated $1.63M.
  • Partners Value Investments first reported a position in Pfizer in Q1 2017 and held it in 1 quarter.
  • Partners Value Investments's Pfizer position peaked at $1.63M in Q1 2017.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Partners Value Investments's 13F filing for Q2 2017, filed 9 Aug 2017.